trigram

This is a table of type trigram and their frequencies. Use it to search & browse the list to learn more about your study carrel.

trigram	frequency
in patients with	626
patients with covid	417
the use of	201
as well as	193
of patients with	188
united states background	148
of venous thromboembolism	137
a total of	133
is associated with	130
venous thromboembolism in	111
in critically ill	110
the risk of	110
patients admitted to	109
of vte in	109
critically ill patients	103
the incidence of	102
the presence of	101
patients with severe	99
of the patients	99
for patients with	98
intensive care unit	98
hospitalized patients with	97
due to the	94
the most common	93
was associated with	91
the time of	91
at the time	91
there was no	84
admitted to the	82
retrospective chart review	81
sickle cell disease	78
associated with a	78
based on the	77
patients with a	77
the treatment of	77
of this study	76
to determine the	72
risk factors for	70
of these patients	70
deep vein thrombosis	68
and management of	68
the development of	67
in hospitalized patients	65
are associated with	63
pediatric patients with	63
patients with acute	63
the number of	63
of the study	62
should be considered	61
more likely to	61
in these patients	61
risk of vte	60
length of stay	60
increased risk of	60
patients who received	60
s of s	59
and treatment of	58
the management of	58
the setting of	58
in the setting	58
in order to	57
in children with	57
traumatic brain injury	56
the prevalence of	56
morbidity and mortality	55
patients with scd	55
the need for	55
to evaluate the	55
the role of	54
in the study	53
a case of	53
the absence of	53
one of the	53
acute respiratory distress	53
respiratory distress syndrome	53
years of age	53
severe acute respiratory	53
patients in the	51
a retrospective chart	51
the patient was	50
in pediatric patients	50
is a rare	50
acute lymphoblastic leukemia	50
in this study	50
there is a	50
the majority of	49
has not been	49
ill patients with	49
chart review of	48
in the icu	48
novel coronavirus pneumonia	48
incidence of vte	48
the diagnosis of	47
total of patients	47
found to have	47
the impact of	47
this study was	47
was used to	46
in acutely ill	46
in patients who	46
with sickle cell	46
in the absence	44
included in the	44
a median of	44
there was a	44
high risk of	44
acutely ill medical	44
the rate of	44
we performed a	43
standard of care	43
vte in patients	43
ill medical patients	42
be considered in	42
was found to	42
there were no	42
an increase in	42
a patient with	42
case of a	42
acute respiratory syndrome	42
in this population	41
all patients with	41
for venous thromboembolism	41
risk for vte	41
acute ischemic stroke	41
were used to	41
at our institution	41
to have a	41
retrospective review of	41
a history of	41
there is no	40
to assess the	40
a diagnosis of	40
all rights reserved	40
of thrombotic complications	39
disseminated intravascular coagulation	39
quality of life	39
this article is	39
of patients who	39
according to the	39
with a median	39
the end of	39
at least one	39
we conducted a	39
at risk for	39
study was to	38
are needed to	38
pulmonary embolism in	38
has been reported	38
icu patients with	38
the importance of	38
associated with increased	38
were associated with	37
were more likely	37
in addition to	37
is protected by	37
article is protected	37
hematopoietic stem cell	37
protected by copyright	37
in the literature	36
the effect of	36
we present a	36
in the treatment	36
the proportion of	36
the course of	36
acute pulmonary embolism	36
the united states	36
were included in	35
we hypothesized that	35
the purpose of	35
respiratory syndrome coronavirus	35
who did not	35
found to be	35
within hours of	35
for the treatment	35
is needed to	35
be associated with	35
patients who were	35
thromboembolism in patients	35
in the united	35
we report a	35
patients had a	35
of children with	34
children with scd	34
we sought to	34
the relationship between	34
the neurocritical care	34
is the first	34
this is a	34
to determine if	33
been associated with	33
was defined as	33
significantly associated with	33
mean age was	33
associated with decreased	32
in those with	32
can lead to	32
can be used	32
this study is	32
at time of	32
compared to the	32
associated with poor	32
the results of	31
were treated with	31
been shown to	31
the addition of	31
associated with the	31
the duration of	31
with novel coronavirus	31
patients who are	31
study is to	31
in all patients	31
medically ill patients	30
review of the	30
performed a retrospective	30
retrospective cohort study	30
incidence of thrombotic	30
a year old	30
who presented with	30
with and without	30
been reported in	30
no evidence of	30
this is the	30
of patients were	30
was started on	30
the patients with	30
purpose of this	30
compared to those	29
patients who had	29
during the study	29
have not been	29
thrombotic complications in	29
with coronavirus disease	29
to describe the	29
patients treated with	29
stem cell transplant	29
with a mean	29
hospitalized medical patients	29
thromboembolism in hospitalized	29
the intensive care	29
before and after	29
the emergency department	28
old male with	28
prior to the	28
the study period	28
the start of	28
is a common	28
the effects of	28
for patients who	28
patients at risk	28
may not be	28
analysis of the	28
treatment of vte	27
the prevention of	27
american society of	27
for management of	27
in the pediatric	27
with severe covid	27
was diagnosed with	27
increased risk for	27
neurocritical care unit	27
pediatric oncology patients	27
as a result	27
is the most	27
a retrospective review	27
and risk factors	27
part of the	27
for at least	27
at increased risk	27
incidence of venous	27
thrombosis and haemostasis	27
did not have	27
aneurysmal subarachnoid hemorrhage	27
in the presence	26
the association between	26
for the prevention	26
for all patients	26
this patient population	26
high incidence of	26
role in the	26
and safety of	26
old female with	26
was treated with	26
of all patients	26
in of patients	26
mg kg day	26
all patients were	26
in the first	26
clinical characteristics of	26
as part of	26
the primary outcome	26
complications in critically	26
a decrease in	26
when compared to	26
the lack of	26
in icu patients	26
did not receive	26
it is important	25
patients with sickle	25
with poor prognosis	25
a cohort of	25
there are no	25
at the end	25
and venous thromboembolism	25
the mean age	25
have been reported	25
acute myeloid leukemia	25
prevalence of venous	25
patients with novel	25
of pulmonary embolism	25
the patient is	25
ill icu patients	25
a retrospective cohort	25
mean age of	25
is important to	25
patients with coronavirus	25
related to the	25
patients with vte	25
report a case	25
critically ill icu	25
likely to have	25
patients who underwent	24
refractory status epilepticus	24
studies are needed	24
vte in covid	24
higher risk of	24
were diagnosed with	24
and young adults	24
in this patient	24
conducted a retrospective	24
the university of	24
society on thrombosis	24
has been shown	24
the efficacy of	24
with a history	24
well as the	24
to be a	24
acute chest syndrome	24
an increased risk	24
severe novel coronavirus	24
risk of thrombosis	23
efficacy and safety	23
number of patients	23
significant difference in	23
the first hours	23
randomized controlled trials	23
after adjusting for	23
in the management	23
the aim of	23
to reduce the	23
thrombosis in patients	23
treatment of venous	23
cumulative incidence of	23
for treatment of	23
society of hematology	23
cause of death	23
and prevention of	23
american college of	23
may be a	23
review of patients	23
the context of	23
red blood cell	23
with severe novel	23
not associated with	23
among patients with	22
prevention of venous	22
the pathogenesis of	22
management of coagulopathy	22
in medical patients	22
the case of	22
in a patient	22
severe coronavirus disease	22
white blood cell	22
management of patients	22
world health organization	22
factors for vte	22
in this setting	22
months of age	22
and in the	22
risk assessment model	22
may be considered	22
none of the	22
low molecular weight	22
coagulopathy in covid	22
objective of this	21
a number of	21
at a median	21
systematic review and	21
no difference in	21
presence of a	21
for the diagnosis	21
risk of bleeding	21
median age of	21
reported in the	21
age at diagnosis	21
of patients admitted	21
vte prophylaxis in	21
coronavirus disease patients	21
of a patient	21
data was collected	21
the occurrence of	21
patients infected with	21
high prevalence of	21
acute kidney injury	21
thromboembolic events in	21
has been associated	21
on thrombosis and	21
cohort of patients	21
rate of vte	21
padua prediction score	21
presented to the	21
as compared to	21
risk factor for	21
admitted to our	21
be considered for	21
poor prognosis in	21
prospective cohort study	21
critically ill covid	21
a report of	21
medical patients at	20
bone marrow failure	20
chart review was	20
prognosis in patients	20
diagnosis and management	20
higher incidence of	20
molecular weight heparin	20
it has been	20
admitted to an	20
significantly higher in	20
patients with cancer	20
to identify the	20
to the icu	20
treatment is associated	20
in accordance with	20
of which were	20
coagulation parameters are	20
neutrophil extracellular traps	20
further studies are	20
was the most	20
appears to be	20
to our knowledge	20
acute brain injury	20
abnormal coagulation parameters	20
patients diagnosed with	20
in the context	20
pediatric hematology oncology	20
the primary efficacy	20
anticoagulant treatment is	20
describe a case	19
embolism in covid	19
patients with sars	19
of the literature	19
such as the	19
patients who died	19
majority of patients	19
a systematic review	19
of the patient	19
mortality in severe	19
with decreased mortality	19
activated partial thromboplastin	19
patients with coagulopathy	19
of pediatric patients	19
review of all	19
central nervous system	19
objective was to	19
decreased mortality in	19
at high risk	19
in severe coronavirus	19
significant differences in	19
associated with an	19
risk of developing	19
higher in the	19
year old male	19
stem cell transplantation	19
adult patients with	19
were found to	19
diagnosis and treatment	19
was higher in	19
the identification of	19
to describe a	19
all hospitalized patients	19
of coronavirus disease	19
was no difference	19
parameters are associated	19
the diagnosis and	19
to the hospital	19
we describe a	19
disease patients with	19
to patients with	19
a result of	19
patients hospitalized for	19
there has been	19
aim of this	19
prevention and treatment	19
of patients had	19
data were collected	18
in patients hospitalized	18
patients hospitalized with	18
is known about	18
venous thromboembolism prophylaxis	18
we aimed to	18
rates of vte	18
of deep vein	18
this was a	18
the present study	18
was significantly higher	18
presented with a	18
during the covid	18
to understand the	18
and the patient	18
is not well	18
were admitted to	18
the international society	18
the most recent	18
patients were included	18
in the past	18
for the management	18
patient is a	18
present a case	18
appear to be	18
were classified as	18
for vte and	18
prevention of thrombosis	18
to the intensive	18
deep venous thrombosis	18
is characterized by	18
due to a	18
consistent with the	18
the two groups	18
partial thromboplastin time	18
during the first	18
we found that	18
to determine whether	18
venous and arterial	18
of coagulopathy in	18
to investigate the	18
patients presenting with	18
factors associated with	18
of the left	18
increase in the	18
all patients who	18
shown to be	18
the study was	17
patients were identified	17
was complicated by	17
u r n	17
little is known	17
analysis was performed	17
patients should be	17
the possibility of	17
in the covid	17
need to be	17
the median age	17
and may be	17
management of venous	17
from january to	17
no significant difference	17
hospital medical center	17
between january and	17
used in the	17
due to its	17
in those patients	17
o o f	17
most of the	17
a l p	17
all patients had	17
are at risk	17
the severity of	17
is one of	17
among hospitalized patients	17
of the disease	17
primary efficacy outcome	17
the level of	17
the padua prediction	17
review and meta	17
complications in covid	17
tissue plasminogen activator	17
whole exome sequencing	17
r n a	17
a retrospective study	17
venous thromboembolic events	17
a median follow	17
of critically ill	17
in medically ill	17
needs to be	17
data from the	17
was assessed by	17
children with cancer	17
in the hospital	17
n a l	17
no statistically significant	17
vein thrombosis in	17
patients with high	17
o u r	17
international society on	17
of the most	17
data on the	17
data suggest that	17
an average of	17
risk for venous	17
blood cell count	17
clinical course and	17
the day of	17
between the two	17
the american college	17
body mass index	17
was no significant	17
admitted to a	17
study of patients	17
the frequency of	17
p r e	17
p r o	17
j o u	17
l p r	17
the potential for	17
use of a	17
in combination with	17
guidelines for management	17
the pediatric population	17
r o o	17
at risk of	17
the safety of	17
be used to	16
of morbidity and	16
a subset of	16
a higher risk	16
associated with covid	16
did not differ	16
in terms of	16
electronic medical record	16
age was years	16
associated with higher	16
of the primary	16
the implementation of	16
a role in	16
was performed on	16
guidelines for the	16
is a major	16
of the international	16
and outcomes of	16
of thrombosis in	16
lmwh or fondaparinux	16
year old female	16
median age was	16
medical patients with	16
been described in	16
childhood cancer survivors	16
was performed to	16
be used for	16
and pulmonary embolism	16
to be associated	16
less likely to	16
a case series	16
of patients infected	16
end of the	16
with history of	16
the objective of	16
the patients who	16
within the first	16
thromboembolic complications in	16
independently associated with	16
in case of	16
the quality of	15
was not associated	15
case series of	15
recognition and management	15
red blood cells	15
considered in patients	15
after initiation of	15
and young adult	15
retrospective analysis of	15
dual antiplatelet therapy	15
glasgow coma scale	15
was present in	15
in patients admitted	15
the patient to	15
pneumonia in wuhan	15
severe hemophilia a	15
in this case	15
all patients admitted	15
medical records of	15
of mechanical ventilation	15
has been used	15
we report the	15
with or without	15
was approved by	15
prevention of vte	15
may be associated	15
time of the	15
for these patients	15
dvt or pe	15
at a single	15
likely to be	15
modified rankin scale	15
prevalence of vte	15
a retrospective analysis	15
no significant differences	15
and efficacy of	15
the safety and	15
with a diagnosis	15
the first case	15
after completion of	15
after hospital discharge	15
the efficacy and	15
observed in patients	15
have a higher	15
two patients had	15
should not be	15
interim guidance on	15
on recognition and	15
may benefit from	15
cerebral blood flow	15
those who did	15
of hospitalized patients	15
a reduction in	15
within days of	15
a variety of	15
to assess for	15
a marker of	15
over the course	15
of the brain	15
a median age	15
pulmonary embolism and	15
involved in the	14
in this cohort	14
there is limited	14
care in the	14
of venous thromboembolic	14
family history of	14
safety and efficacy	14
in hospitalized covid	14
who had a	14
inpatients with covid	14
management of acute	14
in the neurocritical	14
index of suspicion	14
findings suggest that	14
a series of	14
in patients at	14
high rates of	14
review was performed	14
to the study	14
study aims to	14
is known to	14
in the post	14
clinical and laboratory	14
low risk of	14
some of the	14
a need for	14
may have a	14
to the ed	14
and lack of	14
isth interim guidance	14
past medical history	14
we identified patients	14
will be conducted	14
outcomes in patients	14
of the clinical	14
a patient who	14
the world health	14
and is associated	14
the coronavirus disease	14
these patients had	14
von willebrand factor	14
that did not	14
of thrombosis and	14
at our center	14
guidance on recognition	14
acute and chronic	14
the onset of	14
proportion of patients	14
for children with	14
median age at	14
hospitalized for covid	14
difference in the	14
to intensive care	14
arterial thromboembolic complications	14
to estimate the	14
successfully treated with	14
in the case	14
the patient had	14
the median time	14
with acute brain	14
be due to	14
is a life	14
to examine the	14
study will be	14
with a high	14
children with sickle	14
end of induction	14
in the right	14
compared with the	14
as a potential	14
expert panel report	13
there is an	13
in the us	13
the study is	13
case highlights the	13
a higher incidence	13
with a higher	13
will be used	13
young adults with	13
should be used	13
with acute ischemic	13
high levels of	13
with newly diagnosed	13
chest guideline and	13
implications for prevention	13
of the following	13
adult inpatients with	13
with atrial fibrillation	13
in severe covid	13
to those without	13
the primary endpoint	13
is a well	13
anoxic brain injury	13
development of a	13
end of life	13
of death in	13
we aim to	13
may be an	13
in patients receiving	13
a bone marrow	13
sensitivity and specificity	13
upper limit of	13
of patients in	13
and expert panel	13
leading cause of	13
do not have	13
we retrospectively reviewed	13
delayed cerebral ischemia	13
and bone marrow	13
a risk assessment	13
by flow cytometry	13
of sickle cell	13
high risk for	13
the goal of	13
patients with tbi	13
factors for mortality	13
ufh or lmwh	13
and specificity of	13
patients who did	13
of adult inpatients	13
thrombotic or thromboembolic	13
compared to patients	13
with an average	13
and had a	13
were used for	13
serve as a	13
and did not	13
higher rates of	13
mortality of adult	13
for each patient	13
clinical features of	13
in relation to	13
external ventricular drain	13
if the patient	13
were able to	13
admitted to intensive	13
ill hospitalized patients	13
for vte prophylaxis	13
is an important	13
course was complicated	13
common cause of	13
after the first	13
antithrombotic therapy and	13
high rate of	13
and those with	13
were no significant	13
and thrombotic or	13
was seen in	13
there was an	13
bone marrow transplantation	13
we hypothesize that	13
limit of normal	13
this case highlights	13
of childhood cancer	13
or thromboembolic disease	13
that patients with	13
in a cohort	13
to compare the	13
a case report	13
for mortality of	13
pre and post	13
of cases of	13
in pediatric oncology	13
as measured by	13
at the university	13
the potential to	13
mortality in patients	13
to study the	13
and arterial thromboembolic	13
in response to	13
the general population	13
significant increase in	13
a high risk	13
diagnosis of vte	13
males and females	13
the effectiveness of	13
has been described	13
guidance for the	13
guideline and expert	13
of care for	13
risk of venous	13
understanding of the	13
we developed a	13
renal replacement therapy	13
was used for	13
to our hospital	13
for age and	13
course and risk	13
for the first	13
patients who have	13
to the emergency	13
in the ed	12
the expression of	12
electronic medical records	12
male with a	12
of vte and	12
the feasibility of	12
admitted to icu	12
one or more	12
are known to	12
statistically significant difference	12
in patients on	12
will be performed	12
of patients receiving	12
the critically ill	12
was a retrospective	12
higher rate of	12
not been studied	12
a multicenter prospective	12
patients were excluded	12
in the development	12
in our patient	12
the study center	12
of the time	12
small sample size	12
mean age at	12
college of cardiology	12
of thromboprophylaxis in	12
the cost of	12
was to evaluate	12
at least months	12
were compared between	12
those who were	12
we describe the	12
major cause of	12
signs and symptoms	12
first case of	12
acute coronary syndrome	12
were observed in	12
in neurocritical care	12
clinical practice guidelines	12
higher risk for	12
in subjects with	12
used as a	12
as high as	12
management of covid	12
patients with atrial	12
it is unclear	12
were enrolled in	12
guidance from the	12
area under the	12
and duration of	12
a significant difference	12
occurred in patients	12
the electronic medical	12
more than of	12
patients with poor	12
neurocritical care patients	12
many of the	12
severe traumatic brain	12
were in the	12
patients with low	12
to better understand	12
with the use	12
altered mental status	12
the degree of	12
that can be	12
direct oral anticoagulants	12
the study will	12
patients with no	12
in the left	12
is based on	12
the severe acute	12
validation of the	12
european society of	12
was determined by	12
multivariable logistic regression	12
results of the	12
sample size is	12
a mean age	12
followed by a	12
results of this	12
complete blood count	12
observed in the	12
was found in	12
on the day	12
to an academic	12
and number of	12
retrospective study of	12
implementation of the	12
in cases of	12
any of the	12
for this study	12
time of diagnosis	12
risk of death	12
with at least	12
patients with and	12
therapy and prevention	12
out of patients	12
was performed in	12
not appear to	12
multicenter prospective cohort	12
and presence of	12
may result in	12
an increased prevalence	12
patients with pe	12
the upper limit	12
in the emergency	12
the process of	12
patients were treated	12
the association of	12
patients with suspected	12
and clinical characteristics	12
assessment model for	12
this suggests that	12
negative predictive value	12
lmwh or ufh	12
thromboembolism prophylaxis in	12
a poor prognosis	12
shortness of breath	12
in the nccu	12
of icu patients	12
may lead to	12
coagulation of patients	12
a change in	12
magnetic resonance imaging	12
to evaluate for	12
high index of	11
at the study	11
venous thromboembolism and	11
is responsible for	11
course of the	11
are at increased	11
needed to determine	11
pediatric and young	11
in the nicu	11
we used a	11
of death and	11
with increased risk	11
in conjunction with	11
it may be	11
associated with lower	11
a single center	11
used to compare	11
report of the	11
the combination of	11
the mrna expressions	11
and can be	11
and mortality in	11
with a positive	11
time to first	11
logistic regression analysis	11
median age years	11
of patients treated	11
with lmwh or	11
vte and bleeding	11
a single institution	11
use of lmwh	11
was significantly lower	11
bone marrow biopsy	11
has been demonstrated	11
of major bleeding	11
were performed to	11
anticoagulant thromboprophylaxis in	11
middle east respiratory	11
american heart association	11
for a total	11
project was to	11
demographic and clinical	11
due to covid	11
mutations in the	11
was a significant	11
acute medical illness	11
of the initial	11
one patient with	11
for the identification	11
it should be	11
risk factors and	11
of vte among	11
vte risk factors	11
patients with sah	11
identification of hospitalized	11
in the final	11
cerebral edema and	11
based on clinical	11
with high risk	11
we found a	11
of the legs	11
of ischemic stroke	11
is caused by	11
the ability to	11
and days of	11
used for the	11
was notable for	11
days prior to	11
ischemic stroke patients	11
response to treatment	11
and platelet count	11
of vte was	11
higher than the	11
it can be	11
in those who	11
of pediatric cancer	11
suggest that the	11
similar to the	11
increased incidence of	11
prophylaxis for hospitalized	11
under the curve	11
is a significant	11
studies have shown	11
there are few	11
approved by the	11
the clinical course	11
of acute pulmonary	11
at the start	11
were defined as	11
at end of	11
college of medicine	11
there were patients	11
in hospitalized medical	11
significant reduction in	11
in patients without	11
were analyzed using	11
old man with	11
platelet count of	11
further study is	11
of symptomatic vte	11
the ability of	11
patients in a	11
vte in hospitalized	11
and disseminated intravascular	11
primary outcome was	11
for the development	11
all patients received	11
hospital length of	11
the most frequent	11
have been used	11
a pediatric patient	11
it is a	11
of this disease	11
a rare case	11
patients with an	11
of age with	11
is due to	11
used to evaluate	11
the extent of	11
patients with sepsis	11
in a tertiary	11
with severe hemophilia	11
in comparison to	11
conflicts of interest	11
risk of mortality	11
of cardiac arrest	11
of hematology guidelines	11
randomized controlled trial	11
with regard to	11
of an increased	11
subset of patients	11
especially in the	11
known about the	11
are consistent with	11
be related to	11
absolute neutrophil count	11
with an increased	11
direct oral anticoagulant	11
was consistent with	11
study aimed to	11
an incidence of	11
case report of	11
a statistically significant	11
in the majority	11
in intensive care	11
associated with high	11
east respiratory syndrome	11
vte risk assessment	11
dvt and pe	11
were reviewed for	11
cd and cd	11
patients with ischemic	11
the care of	11
bone marrow evaluation	11
cd t cells	11
glasgow outcome scale	11
hematology guidelines for	11
model for the	11
for the study	11
to improve the	11
had a higher	11
to increase the	11
the initiation of	11
she was started	11
in the patients	11
the ovid study	11
risk of infection	11
the burden of	11
to develop a	11
for those with	11
for critically ill	11
cause of morbidity	11
levels of d	11
of dvt in	11
for the duration	11
treatment of acute	11
awareness of an	11
lead to a	11
was admitted to	11
day of admission	11
of hospitalized medical	11
not statistically significant	11
pharmacologic vte prophylaxis	11
it is not	11
with respect to	10
patients in whom	10
academic hospital in	10
many of these	10
in patients undergoing	10
were identified with	10
survived to discharge	10
was confirmed in	10
from patients with	10
rivaroxaban for thromboprophylaxis	10
in acute ischemic	10
year overall survival	10
patients who developed	10
characteristics of coronavirus	10
thromboprophylaxis in acutely	10
in the last	10
met inclusion criteria	10
these patients are	10
objective is to	10
in collaboration with	10
rare case of	10
during hospital stay	10
may be useful	10
median of days	10
in a pediatric	10
patients with non	10
point of care	10
be able to	10
to identify patients	10
adjusted for age	10
who presented to	10
have a high	10
accepted article this	10
a prospective study	10
on the use	10
patients from the	10
of disseminated intravascular	10
can be considered	10
completion of the	10
patients with ds	10
patient with a	10
hospitalized with covid	10
of vte is	10
significant decrease in	10
polymerase chain reaction	10
used to determine	10
we present the	10
responsible for the	10
is important for	10
with the addition	10
that there is	10
was used in	10
to the high	10
coagulopathy and disseminated	10
pt and aptt	10
sought to determine	10
patient was started	10
in a large	10
for thromboprophylaxis in	10
pathogenesis of vte	10
aim was to	10
and bleeding risk	10
for vte in	10
these patients were	10
on day of	10
this pilot study	10
patients with asah	10
of t cells	10
subcutaneously every hours	10
has been well	10
for up to	10
with severe sars	10
percentage of patients	10
with poor outcome	10
of the participants	10
novel coronavirus in	10
between march and	10
the hypothesis that	10
of vte patients	10
ochsner health system	10
in the critically	10
elevation myocardial infarction	10
patients aged years	10
logistic regression model	10
not been well	10
inpatient and outpatient	10
each of the	10
ranged from to	10
versus host disease	10
venous thromboembolism risk	10
patients are at	10
end of therapy	10
of coagulopathy and	10
acutely ill hospitalized	10
depending on the	10
was performed for	10
was noted in	10
therapy should be	10
median time to	10
of status epilepticus	10
biopsy of the	10
vte prophylaxis for	10
it is possible	10
intensive care units	10
cell acute lymphoblastic	10
to participate in	10
thromboembolism in critically	10
study is needed	10
in the analysis	10
randomized clinical trial	10
research is needed	10
is a retrospective	10
lost to follow	10
a high incidence	10
were excluded from	10
this study aims	10
mrna expressions of	10
to be at	10
who are not	10
and length of	10
hypercoagulability of covid	10
patient had a	10
at low risk	10
was well tolerated	10
the novel coronavirus	10
vitamin k antagonist	10
clearance ml min	10
extracorporeal membrane oxygenation	10
patients have been	10
graft versus host	10
in absence of	10
were significantly higher	10
and severity of	10
between vte and	10
an academic hospital	10
patients without covid	10
with ischemic stroke	10
of the first	10
patients who develop	10
is thought to	10
more common in	10
of bone marrow	10
used to identify	10
bone marrow aspirate	10
in the early	10
female presented with	10
a major cause	10
article this article	10
study was conducted	10
thromboembolism in acutely	10
of the right	10
january to december	10
characterized by a	10
the patient developed	10
outcomes of patients	10
resulted in a	10
results suggest that	10
and the median	10
creatinine clearance ml	10
the american society	10
hospital mortality was	10
half of the	10
in the pathogenesis	10
neurocritical care units	10
activation of the	10
report of a	10
in out of	10
but did not	10
in all hospitalized	10
coronavirus disease in	10
differences in the	10
may be due	9
days after hospital	9
adjusting for age	9
three patients with	9
at the site	9
of a pediatric	9
one patient developed	9
study sought to	9
of the risk	9
at higher risk	9
a review of	9
in patients in	9
seen in the	9
factors such as	9
minimal residual disease	9
who do not	9
pediatric patient with	9
led to a	9
this case series	9
with mortality in	9
patients were diagnosed	9
caused by the	9
to those with	9
implementation of a	9
the fact that	9
knowledge of the	9
there may be	9
those who received	9
mechanical ventilation and	9
for hospitalized and	9
of all pediatric	9
patients were enrolled	9
not significantly different	9
in a randomized	9
neurointensive care unit	9
in the present	9
noted to be	9
and patients with	9
electronic health record	9
these patients is	9
dimer and fibrinogen	9
the remaining patients	9
prospective studies are	9
the informed consent	9
than in the	9
is consistent with	9
completion of therapy	9
diagnosed with a	9
was calculated for	9
and after the	9
the incidence and	9
hours of admission	9
nonhospitalized medical patients	9
with acute respiratory	9
by the patient	9
size of the	9
the control group	9
obtained from the	9
reported to be	9
and standardization committee	9
conflict of interest	9
we believe that	9
over the past	9
of vte prophylaxis	9
to those who	9
has the potential	9
is to evaluate	9
have been shown	9
been reported to	9
the benefit of	9
were identified and	9
internal carotid artery	9
and location of	9
the risk for	9
the cumulative incidence	9
patient and family	9
could not be	9
of the studies	9
in of the	9
dose of lmwh	9
treatment for covid	9
on how to	9
and loss of	9
mg twice daily	9
scientific and standardization	9
with severe disease	9
in the general	9
reduce the risk	9
of enoxaparin sodium	9
was detected in	9
treated at the	9
is recommended to	9
on patients with	9
yet to be	9
those patients who	9
will be provided	9
who were admitted	9
compared to controls	9
medical history of	9
and symptoms of	9
who were not	9
in sickle cell	9
from the same	9
are more likely	9
of the high	9
and the other	9
a previously healthy	9
in of cases	9
associated with acute	9
outside of the	9
patients with dvt	9
a rate of	9
to help guide	9
who were treated	9
including those with	9
members of the	9
patients included in	9
and history of	9
bone marrow transplant	9
to of patients	9
the records of	9
anticoagulated severe covid	9
events in anticoagulated	9
pulmonary thrombosis in	9
analysis of patients	9
an important role	9
defined as the	9
disease in china	9
dimer levels were	9
in anticoagulated severe	9
next generation sequencing	9
less than years	9
b t m	9
due to severe	9
care unit for	9
the first year	9
enrolled in the	9
increase the risk	9
a high prevalence	9
in the non	9
guidance on the	9
access to the	9
patients with the	9
adolescents and young	9
of the manuscript	9
management of pediatric	9
there have been	9
a hypercoagulable state	9
vast majority of	9
was performed using	9
and nonhospitalized medical	9
used in patients	9
are required to	9
accordance with the	9
management of these	9
increased from to	9
to correlate with	9
mean arterial pressure	9
in a young	9
during the course	9
was performed and	9
have also been	9
in the process	9
academic medical center	9
were consistent with	9
was able to	9
on hospital day	9
had at least	9
in the two	9
for those who	9
after cardiac arrest	9
months off therapy	9
the patients had	9
elevated levels of	9
presented to our	9
been found to	9
in the intensive	9
may also be	9
were retrospectively reviewed	9
level of care	9
we investigated the	9
in the most	9
and there is	9
in clinical trials	9
pediatric intensive care	9
autoimmune hemolytic anemia	9
was based on	9
t cell immunity	9
the primary objective	9
had evidence of	9
patients treated at	9
days of enrolment	9
the vast majority	9
the inclusion criteria	9
up to of	9
safe and effective	9
because of the	9
a quality improvement	9
clinically relevant bleeding	9
patients and families	9
in the same	9
the european society	9
venous thrombosis in	9
to improve outcomes	9
we did not	9
therapy in the	9
at any time	9
was identified in	9
efs and os	9
compared to non	9
the need to	9
with worse outcomes	9
old female presented	9
the leading cause	9
the same time	9
strongly associated with	9
a high rate	9
to account for	9
he was treated	9
on the presence	9
hospitalized and nonhospitalized	9
and thrombosis in	9
in critical care	9
middle cerebral artery	9
head and neck	9
one patient was	9
infected with covid	9
of the data	9
patients with aml	9
was observed in	9
important role in	9
not differ between	9
thought to be	9
the percentage of	9
diagnosed with vte	9
t cells and	9
days of randomization	9
most common cause	9
receiver operating characteristic	9
from the study	9
analyses were performed	9
in ambulatory patients	9
review was conducted	8
was used as	8
reported in patients	8
patients with aneurysmal	8
prior to discharge	8
routine use of	8
average number of	8
the need of	8
to define the	8
and was found	8
elevated in patients	8
it is reasonable	8
in the acute	8
of care and	8
after hospitalization for	8
participation in the	8
significant difference between	8
male presented with	8
and critical care	8
use of thromboprophylaxis	8
in patients treated	8
in the clinical	8
is a year	8
we suggest that	8
records of patients	8
occurred in the	8
we assessed the	8
were obtained from	8
assessment of the	8
decision was made	8
central venous catheters	8
when compared with	8
we plan to	8
study was performed	8
the administration of	8
one patient had	8
with scd and	8
and mortality rates	8
ultrasonography of the	8
the frequency and	8
of novel coronavirus	8
infected with novel	8
nature of the	8
features of patients	8
had significantly higher	8
observed in covid	8
increase in major	8
of those with	8
targeted temperature management	8
is recommended in	8
and to evaluate	8
contribute to the	8
number of days	8
in a significant	8
may wish to	8
to characterize the	8
higher doses of	8
to the development	8
our objective was	8
was lower in	8
coronary artery disease	8
with a lower	8
mechanically ventilated patients	8
old female who	8
of hospital admission	8
the ochsner health	8
to our institution	8
found that the	8
total number of	8
with no evidence	8
two patients were	8
lower risk of	8
and months after	8
were less likely	8
patients with all	8
up to days	8
society of cardiology	8
for the primary	8
and to identify	8
hospitalization for medical	8
days after discharge	8
risk factors in	8
were noted in	8
the likelihood of	8
an association between	8
postdischarge vte prophylaxis	8
is difficult to	8
will take place	8
was discharged home	8
during their hospital	8
the discretion of	8
a combination of	8
data suggests that	8
thrombosis in covid	8
who had been	8
of those who	8
of hematoma expansion	8
of the american	8
anticoagulation in patients	8
packed red blood	8
diagnosed with cancer	8
during induction therapy	8
at least days	8
incidence of symptomatic	8
significant difference was	8
and are associated	8
the decision was	8
of patients hospitalized	8
at a large	8
those with severe	8
primary diagnosis of	8
was not significantly	8
and exclusion criteria	8
associated with severe	8
which may be	8
presented with acute	8
obese patients with	8
antibodies in patients	8
acute limb ischemia	8
high bleeding risk	8
with acute lymphoblastic	8
years or older	8
high dose steroids	8
a trend towards	8
baylor college of	8
a prospective cohort	8
italian society on	8
was designed to	8
and she was	8
we are currently	8
patient with covid	8
a prospective observational	8
of a year	8
duration of the	8
goal was to	8
in line with	8
incidence of pulmonary	8
months after diagnosis	8
for pediatric patients	8
two of the	8
increase in d	8
the indications for	8
cd count kg	8
goal of this	8
these findings support	8
in one patient	8
hours after admission	8
were randomized to	8
between the ages	8
deletion duplication analysis	8
lower in patients	8
were unable to	8
anticoagulant therapy during	8
been used for	8
could be a	8
has never been	8
to years old	8
is common in	8
during this time	8
were significantly associated	8
in the other	8
is warranted to	8
in the immediate	8
with aneurysmal subarachnoid	8
and associated with	8
thrombosis and pulmonary	8
this was not	8
has been suggested	8
to initiation of	8
as soon as	8
an association with	8
patients will be	8
at the discretion	8
and antiphospholipid antibodies	8
on the diagnosis	8
needed to confirm	8
is to describe	8
task force on	8
a group of	8
were compared using	8
the cause of	8
testing was performed	8
the concept of	8
this project was	8
series of patients	8
cohort study of	8
did not identify	8
be used in	8
and of those	8
be considered as	8
hematology oncology fellowship	8
the pathophysiology of	8
and risk of	8
and icu los	8
moderate to severe	8
survivors of cardiac	8
increases the risk	8
out of the	8
the clinical trial	8
the left lower	8
the expressions of	8
patients admitted with	8
was switched to	8
was made to	8
common in patients	8
a child with	8
external validation of	8
should be given	8
prior history of	8
were not significantly	8
around the world	8
children and young	8
was to determine	8
patient presented with	8
patients were admitted	8
location of the	8
a majority of	8
healthcare of atlanta	8
who are at	8
part of a	8
severity of illness	8
blood cultures in	8
disease severity and	8
lopinavir ritonavir or	8
score of or	8
a lack of	8
consistent with a	8
can be challenging	8
with proximal dvt	8
of the cases	8
be used as	8
in adults with	8
patients with confirmed	8
has been previously	8
is a frequent	8
of poor outcome	8
vte and non	8
patients with mechanical	8
regarding the use	8
patients in this	8
sickle cell anemia	8
patients in intensive	8
who present with	8
may be used	8
of hospital stay	8
at diagnosis of	8
percent of patients	8
on the other	8
as early as	8
vitamin b deficiency	8
a high index	8
the clinical and	8
the introduction of	8
shown to have	8
critical care unit	8
could be used	8
vitamin k antagonists	8
international medical prevention	8
patients has been	8
the standard of	8
vte in the	8
as a marker	8
the bone marrow	8
an intensive care	8
with fever and	8
included patients with	8
and need for	8
with increased mortality	8
the hypercoagulable state	8
the benefits of	8
at diagnosis and	8
augmented renal clearance	8
included in this	8
observational study of	8
should focus on	8
was positive for	8
guideline for the	8
patients with proximal	8
these findings suggest	8
embolism in patients	8
clinical and radiographic	8
car t cells	8
patients at high	8
is a potentially	8
to hospital discharge	8
patients met inclusion	8
doses of lmwh	8
the platelet count	8
was transitioned to	8
of intracranial hemorrhage	8
in the previous	8
braf v e	8
dimer levels and	8
available on the	8
quality improvement project	8
g dl and	8
in patients and	8
the high risk	8
the study population	8
was significantly associated	8
von willebrand disease	8
play a role	8
complications such as	8
patients that received	8
the utility of	8
for patients in	8
well as a	8
of treatment with	8
aged or older	8
and of patients	8
use of mechanical	8
the most severe	8
diagnosis of covid	8
patients with other	8
mean duration of	8
old male presented	8
risk of major	8
the site of	8
to rule out	8
characteristics and outcomes	8
coronavirus in wuhan	8
in pe patients	8
for medical illness	8
patients hospitalized in	8
for use in	8
the surface of	8
patients with b	7
or in the	7
vwd and eds	7
of extended thromboprophylaxis	7
were markedly up	7
of anticoagulation in	7
and major bleeding	7
of thrombotic events	7
large vessel occlusion	7
calculated using the	7
chemotherapy and radiation	7
to the pediatric	7
level of consciousness	7
with intracerebral hemorrhage	7
a randomized controlled	7
randomized clinical trials	7
a key role	7
is a prospective	7
samd l mutation	7
a platelet count	7
the first days	7
were started on	7
in the pe	7
the nature of	7
week history of	7
march and may	7
with r r	7
with severe acute	7
initial parenteral anticoagulation	7
platelet count was	7
weeks of treatment	7
and time to	7
of thromboelastography findings	7
and has been	7
was reported in	7
of the covid	7
of severe acute	7
female with a	7
occurrence of vte	7
in healthy subjects	7
at that time	7
did not improve	7
sought to describe	7
and major thromboembolic	7
to the diagnosis	7
peking union medical	7
in patients that	7
acute respiratory failure	7
for the patient	7
multivariate logistic regression	7
prevention registry on	7
percutaneous coronary intervention	7
associated with worse	7
a neurocritical care	7
in up to	7
not able to	7
inclusion and exclusion	7
level of evidence	7
mri of the	7
tested positive for	7
diagnosed with covid	7
the probability of	7
using descriptive statistics	7
treatment of the	7
treatment and prevention	7
we propose that	7
union medical college	7
but there is	7
in nonsurgical patients	7
of informed consent	7
and will be	7
studies on the	7
the medenox study	7
considered in the	7
our understanding of	7
the other hand	7
diffuse alveolar damage	7
were identified in	7
was no evidence	7
the treating physician	7
along with the	7
calculated for each	7
admission to the	7
of patients diagnosed	7
of all children	7
outcomes associated with	7
did not meet	7
may be at	7
for more than	7
antiphospholipid antibodies in	7
of this project	7
of mortality in	7
and the need	7
of adult patients	7
thromboprophylaxis in patients	7
central venous access	7
a significant decrease	7
a predictor of	7
for high risk	7
in a single	7
patients with primary	7
from the anticoagulation	7
was noted to	7
use of anticoagulation	7
are the most	7
the united kingdom	7
these data suggest	7
the patients in	7
we recommend that	7
complications of covid	7
a comparison of	7
prevalence of asymptomatic	7
statistical analysis was	7
this case report	7
positive and negative	7
abnormalities in the	7
the most frequently	7
reduction in the	7
therapy during the	7
been observed in	7
computed tomography pulmonary	7
the rarity of	7
collected and analyzed	7
to review the	7
were identified as	7
coagulopathy and thrombosis	7
antithrombotic therapy for	7
doses of anticoagulation	7
in healthy volunteers	7
randomization will be	7
by the world	7
acute intracranial hemorrhage	7
failure to thrive	7
a score of	7
of neurocritical care	7
no patient had	7
flow nasal cannula	7
with status epilepticus	7
with the patient	7
patients aged or	7
posterior reversible encephalopathy	7
univariate and multivariate	7
clinical management of	7
the correlation between	7
was admitted with	7
is an effective	7
patients admitted for	7
wish to consider	7
are responsible for	7
for pulmonary embolism	7
have shown that	7
was achieved in	7
characteristics of the	7
primary endpoint was	7
urinary tract infections	7
systolic blood pressure	7
no contraindication exists	7
mutation in the	7
critically ill patient	7
not treated with	7
of our study	7
group had a	7
should be monitored	7
at and months	7
the first weeks	7
a trial of	7
diffuse myocardial fibrosis	7
report the first	7
is reasonable to	7
risk of bias	7
of the current	7
a common complication	7
were found in	7
significantly lower in	7
associated with improved	7
work is needed	7
a potential therapeutic	7
twice a day	7
therapy for vte	7
correlated with the	7
in the pre	7
patients who present	7
to the start	7
was negative for	7
fatal and major	7
wilcoxon rank sum	7
of icu admission	7
the indication for	7
in our cohort	7
after controlling for	7
academic medical centers	7
spontaneous ich patients	7
clinical course of	7
data in the	7
there are several	7
old woman with	7
report of thromboelastography	7
significant proportion of	7
health care workers	7
h car t	7
and had an	7
thromboelastography findings and	7
study suggests that	7
risks and benefits	7
improvement in the	7
clinical guidance from	7
with resolution of	7
primary objective was	7
an outside hospital	7
were screened for	7
vte in nonsurgical	7
this study will	7
due to their	7
in our study	7
prophylaxis in medical	7
three times daily	7
an external ventricular	7
a period of	7
impact on the	7
the study of	7
an analysis of	7
parameters of hemostasis	7
significantly increased in	7
prophylactic doses of	7
use of oral	7
icu length of	7
evaluate the efficacy	7
performed to assess	7
were identified from	7
total sample size	7
median duration of	7
were performed in	7
a nationally representative	7
or older with	7
in which the	7
occurred in of	7
significant impact on	7
the pediatric oncology	7
versus those who	7
vte in this	7
from symptom onset	7
dedicated neurocritical care	7
not seem to	7
study was approved	7
pediatric cancer survivors	7
measured by the	7
risk factors of	7
likely to receive	7
this may be	7
those patients with	7
is a key	7
clinicians may wish	7
this study sought	7
was calculated using	7
is defined as	7
was placed on	7
a higher rate	7
with high dose	7
four patients had	7
developed in collaboration	7
continued to have	7
of the two	7
vte rates in	7
and quality of	7
in the care	7
were compared to	7
in view of	7
vein thrombosis and	7
age of patients	7
was not different	7
patients had no	7
higher in patients	7
prospective observational study	7
to analyze the	7
described in the	7
compromised t cell	7
as assessed by	7
block group poverty	7
our data suggest	7
nonhospitalized patients with	7
is limited data	7
oral anticoagulant therapy	7
confidence interval ci	7
also associated with	7
the exception of	7
of the lower	7
days after the	7
management in the	7
the results from	7
here we present	7
be conducted in	7
of care in	7
enoxaparin mg daily	7
associated acute respiratory	7
age and gender	7
outcome was defined	7
patients with brain	7
time to enteral	7
the age of	7
a significant proportion	7
the choice of	7
in the differential	7
and review of	7
of the total	7
clinical trials in	7
prophylaxis in acutely	7
reported case of	7
as the first	7
and other parameters	7
were evaluated for	7
closely related to	7
small molecule inhibitors	7
history of a	7
and of the	7
with advanced cancer	7
view of the	7
as evidenced by	7
proximal dvt or	7
in the outpatient	7
third of patients	7
patients were evaluated	7
of which is	7
positive blood cultures	7
biopsy was performed	7
found in the	7
a significant reduction	7
right heart strain	7
other parameters of	7
care unit with	7
age of years	7
was no statistically	7
likely due to	7
findings and other	7
their hospital stay	7
in treatment of	7
the patient and	7
coagulopathy and antiphospholipid	7
neurocritical care society	7
the differential diagnosis	7
of evd placement	7
considered to be	7
the timing of	7
to create a	7
ischemic stroke and	7
the first to	7
hemolytic uremic syndrome	7
the anticoagulation forum	7
interim clinical guidance	7
thrombosis in hospitalized	7
and use of	7
the outpatient setting	7
is possible that	7
was carried out	7
in obese patients	7
of vitamin k	7
primary and metastatic	7
and treated with	7
heparin in covid	7
of or more	7
to improve patient	7
to prevent vte	7
a randomized trial	7
of blood flow	7
for medical patients	7
excluded from the	7
up of months	7
in group b	7
dose anticoagulation with	7
inclusion criteria were	7
independent predictors of	7
our findings suggest	7
is a novel	7
was obtained from	7
time of admission	7
therapy can be	7
results in a	7
differential diagnosis of	7
optimal management of	7
by the severe	7
in a child	7
of anticoagulant thromboprophylaxis	7
in blood coagulation	7
prior to initiation	7
is higher than	7
and vte prophylaxis	7
h k m	7
reversible encephalopathy syndrome	7
urine specific gravity	7
duration of anticoagulation	7
the most commonly	7
or inability to	7
with a primary	7
the authors have	7
estimated day survival	7
would benefit from	7
median time from	7
withdrawal of care	7
due to lack	7
the first report	7
has emerged as	7
the pediatric intensive	7
poor outcome in	7
at the same	7
in a study	7
for vte disease	7
with a past	7
years old with	7
and in patients	7
of metastatic disease	7
hospital for children	7
in patients presenting	7
did not affect	7
prior to admission	7
with the presence	7
practical guidance for	7
young adult patients	7
to have an	7
mg kg subcutaneously	7
and anticoagulant therapy	7
is seen in	7
elevated intracranial pressure	7
all cell lines	7
therapy in patients	7
associated with infection	7
that may be	7
insight into the	7
was conducted using	7
further research is	7
after hospital admission	7
in a recent	7
can present with	7
the criteria for	7
and in vivo	7
consecutive patients with	7
regression was used	7
medical prevention registry	7
we retrospectively analyzed	7
january and june	7
improve outcomes in	7
optic nerve sheath	7
in the course	7
in more than	7
defined as a	7
at hospital discharge	7
those who had	7
any hospitalization or	7
in incidence of	7
and compared to	7
she was treated	7
these patients should	7
with severe ncp	7
patients with refractory	7
cell lines and	7
is the only	7
test was used	7
symptomatic vte is	7
continuous renal replacement	7
position paper from	7
the ages of	7
to lack of	7
with the exception	7
limited data on	7
with traumatic brain	7
thromboembolism in the	7
spontaneous intracerebral hemorrhage	7
of low molecular	7
new york city	7
available in the	6
all patients underwent	6
significant association between	6
was higher than	6
been previously reported	6
patients without pe	6
in patients diagnosed	6
a sensitivity of	6
the inability to	6
by recent laboratory	6
the range of	6
can also be	6
data from patients	6
children and adolescents	6
hospital in the	6
in pe group	6
center retrospective study	6
anticoagulation should be	6
between the groups	6
for status epilepticus	6
four patients were	6
after the start	6
to the time	6
started on sirolimus	6
suspicion for vte	6
was available for	6
of the present	6
taking into account	6
to determine how	6
of induction therapy	6
participating in the	6
no studies have	6
even in the	6
hospitalized patients and	6
is not recommended	6
and should be	6
total of children	6
for thrombosis and	6
patients with clinical	6
survival of days	6
vitro and in	6
peripherally inserted central	6
controlling for age	6
confirmed by recent	6
a consumption coagulopathy	6
was done using	6
conducted in the	6
identify patients who	6
all of which	6
thrombosis and management	6
is the number	6
expression of cdc	6
institutional review board	6
intravascular coagulation of	6
were compared with	6
response to therapy	6
the patients were	6
the dose of	6
small number of	6
of the medical	6
major clinically relevant	6
between patients with	6
well as other	6
lvh on ekg	6
mean length of	6
during treatment and	6
in adult patients	6
used to treat	6
participated in the	6
we anticipate that	6
blood cell and	6